Clinical trial

NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel

NCT00229593 · University of Washington, Other · Completed

Key facts

NCT number NCT00229593
Title NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel
Official title A Randomized, Open Label Clinical Trial to Evaluate if Nestorone Gel Has Gonadotropin Suppressive Activity and if Nestorone in Combination With Testosterone Will Have an Additive Effect on Gonadotropin Suppression When Applied Transdermally in Healthy Men
Acronym NES-1
Lead sponsor University of Washington, Other
Collaborators Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Contraception
Intervention type Drug
Interventions Nestorone gel, Testosterone Gel
Enrollment 140
Start date Sep 1, 2005
Primary completion Jan 1, 2007
Completion Jan 1, 2007
First posted Sep 29, 2005
Last update posted Dec 4, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies